It can prevent the formation of homogeneity and heterodimer of HER2 and EGFR in tumor cells and inhibit its own phosphorylation and block the activation of downstream signaling pathways, thereby inhibiting tumor cell growth (Blair, 2018). The gene discussed is ERBB2; the disease is neoplasm.